About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
2020 ASCO Virtual Direct™ Highlights
Boston
Breast
GYN
Lung
GI
GU
Skin
Hematologic Oncology
Head&Neck
Supportive/Palliative Care
St. Louis
Breast
GYN
Lung
GI
GU
Skin
Hematologic Oncology
Head&Neck
Supportive/Palliative Care
Basic Science
Jacksonville
Breast
Hematologic Oncology
Lung
GI
GU
GYN
Skin
Head&Neck
Basic Science
Philadelphia
GI
GU
Lung
Skin
Hematologic Oncology
Breast
Supportive/Palliative Care
Head&Neck
GYN
Denver
Breast
Hematologic Oncology
Lung
GU
Skin
GYN
Head&Neck
Basic Science
San Francisco
Breast
Lung
GU
Hematologic Oncology
Skin
GI
GYN
Head&Neck
Business
Las Vegas
GI
GU
Hematologic Oncology
Skin
Lung
Head&Neck
GYN
Business
San Juan
Breast
GI
Hematologic Oncology
Skin
GYN
Basic Science
Head and Neck
Supportive and Palliative Care
Business
Events
Skin
08:11
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Highlights on Rare Melanoma Types: Is Anti-PD-1 + VEGFi Axitinib Effective in Mucosal Melanoma?
FEATURING
Zeynep Eroglu
35 views
August 13, 2020
13:17
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on Post anti-PD-1 Options in Advanced Melanoma: Can We Have an Effective Regimen With the Addition of Low-Dose Ipi to Pembro?
FEATURING
Zeynep Eroglu
56 views
August 13, 2020
16:32
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on Neoadjuvant Melanoma: Neoadjuvant Ipi/Nivo or Adjuvant Ipi/Nivo? What Is the Optimal Dosing of the Neoadjuvant Combination?
FEATURING
Zeynep Eroglu
244 views
August 13, 2020
1
08:58
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Highlights on Adjuvant Therapy in Stage III Melanoma: Is There a RFS Benefit to Adjuvant Pembrolizumab in Resected High-Risk Disease? What Is the Benefit of Dab + Tram in BRAF V600E / V600K Melanoma?
FEATURING
Zeynep Eroglu
55 views
August 13, 2020
